Agilent Podcast Series
According to the World Health Organization (WHO), cancer is a leading cause of death worldwide.1 It is estimated that 10 million people lose their lives to cancer every year, and the total annual economic cost of cancer is approximately US$1.16 trillion.2
For many decades, the cancer research community has worked tirelessly to help solve scientific challenges for overcoming this ancient disease, which was thought to be first documented in around 2600 B.C.3, 4
This episode of the Agilent Podcast Series investigates what is now being coined as ‘the golden age of cancer research’, while exploring ongoing milestones, scientific advancements, and the dedicated efforts being made to help improve patient outcomes.
Sam Godfrey, Ph.D., Research Information Team Lead at Cancer Research UK
Scott Lowe, Ph.D., Chair of the Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Mark Garner, Ph.D., Global Cancer Segment Market Manager at Agilent Technologies
References [1 - 4]:
What is cancer? | World Cancer Day
Immunotherapy and the revolution in cancer | Agilent
S. Mukherjee. The Emperor of All Maladies: A Biography of Cancer. Scribner, New York (2010), pp. 39–41
The Agilent Podcast Series explores thought-provoking themes by showcasing some of the cutting-edge work being done by Agilent customers and collaborators around the world.